Barclays set a €114.20 ($132.79) price target on Hannover Re (FRA:HNR1) in a report issued on Monday, Borsen Zeitung reports. The firm currently has a sell rating on the stock.

Several other equities research analysts have also commented on HNR1. HSBC dropped their price target on Canada Goose from C$62.00 to C$55.00 and set a buy rating for the company in a research note on Monday, June 3rd. Independent Research set a €85.00 ($98.84) price target on Henkel AG & Co KGaA and gave the stock a sell rating in a research note on Tuesday, May 7th. Royal Bank of Canada set a €86.00 ($100.00) target price on Henkel AG & Co KGaA and gave the stock a neutral rating in a research report on Tuesday, May 7th. DZ Bank reaffirmed a neutral rating on shares of Hannover Re in a research report on Monday, June 24th. Finally, Deutsche Bank reaffirmed a hold rating and issued a GBX 1,775 ($23.19) target price on shares of in a research report on Wednesday, June 26th. Five investment analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company. Hannover Re has an average rating of Hold and an average target price of €120.66 ($140.30).

Shares of FRA:HNR1 opened at €142.70 ($165.93) on Monday. The stock’s 50-day moving average price is €140.02. Hannover Re has a 12 month low of €94.75 ($110.17) and a 12 month high of €116.37 ($135.31).

Hannover Re Company Profile

Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.

Featured Story: How to Use a Moving Average for Trading 

Analyst Recommendations for Hannover Re (FRA:HNR1)

Receive News & Ratings for Hannover Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Re and related companies with MarketBeat.com's FREE daily email newsletter.